Allergic sensitization enhances the contribution of Rho‐kinase to airway smooth muscle contraction

Authors:

Abstract
Repeated allergen challenge has been shown to increase the role of Rho‐kinase in airway smooth muscle (ASM) contraction. We considered the possibility that active allergic sensitization by itself, that is, without subsequent allergen exposure, could be sufficient to enhance Rho‐kinase‐mediated ASM contraction. Guinea pigs were actively IgE‐sensitized to ovalbumin (OA), using Al(OH)3 as adjuvant. Contractile responsiveness to Gq‐coupled receptor agonists (methacholine, histamine or PGF2α) was investigated in tracheal rings. No effect of sensitization was observed on basal‐ and methacholine‐induced myogenic tone. In contrast, potency of histamine and PGF2α increased, that is, EC50 decreased, after OA‐sensitization by 2.6‐ and 4.7‐fold, respectively, without effect on maximal contraction (Emax). Basal tone in preparations from both control and OA‐sensitized animals was strongly decreased in the presence of the Rho‐kinase inhibitor (+)‐(R)‐trans‐4‐(1‐aminoethyl)‐N‐(4‐pyridyl) cyclohexane carboxamide (Y‐27632) (1 μM). In control preparations, the Emax and potency of histamine were unaffected by Y‐27632, but were decreased for PGF2α (by 38.2% and 2.0‐fold, respectively). However, in preparations from OA‐sensitized animals, Y‐27632 induced a significant reduction in Emax (33.5%) and potency (2.3‐fold) of histamine and of PGF2α (48.3% and 6.6‐fold, respectively), normalizing the OA‐sensitization‐induced increase in sensitivity toward these agonists. We also investigated the contribution of Rho‐kinase in vivo by measuring airway responsiveness toward inhaled histamine in permanently instrumented, unanaesthetized control and OA‐sensitized guinea pigs. Treatment with Y‐27632 by inhalation (5 mM, nebulizer concentration) decreased airway responsiveness toward histamine both in control and OA‐sensitized animals. However, the histamine PC100 ratio pre/post Y‐27632 inhalation was significantly smaller in OA‐sensitized animals as compared to control animals, indicating an enhanced contribution of Rho‐kinase. Expression of RhoA, an upstream activator of Rho‐kinase, was significantly increased (2.6‐fold) in lung homogenates of OA‐sensitized guinea pigs compared to control animals, as determined by Western analysis. In conclusion, the results show a receptor‐dependent role of Rho‐kinase in agonist‐induced ASM contraction. The contribution of Rho‐kinase to contractile airway responsiveness, both in vivo and ex vivo, is augmented after active allergic sensitization, as a consequence of increased expression of RhoA presumably. Inhibition of the RhoA/Rho‐kinase pathway may be considered a useful pharmacotherapeutical target in allergy and asthma. British Journal of Pharmacology (2004) 143, 477–484. doi:10.1038/sj.bjp.0705903

This publication has 42 references indexed in Scilit: